The enzyme carnitine acetyltransferase [acetylCoA-(-)-carnitine O-acetyltransferase, EC 2.3.1.7] is widespread and active in animal tissues (Beenakkers & Klingenberg, 1964) , but as yet no precise physiological role can be ascribed to it (Fritz, 1965) . It might be expected, however, that a study of the metabolic disturbances caused by specific inhibitors of the enzyme would yield information relevant to this problem.
The effects of bromoacetyl derivatives of CoA and carnitine on isolated preparations of carnitine acetyltransferase have been investigated. It was hoped that such substrate analogues, after being specifically bound to the enzyme, would alkylate susceptible amino acid residues at or near the active centre. Similar active-site-directed inhibitors have been designed for a number of enzymes (Baker, 1967) . Although it appears that bromoacetyl-(-)-carnitine at least may be used to inhibit the enzyme irreversibly and probably in the manner envisaged above, it has also become clear that under certain conditions either analogue can cause a much more rapid inhibition, which is slowly reversible. It is the somewhat novel nature of this rapid inhibition that is reported here. 8 Preliminary reports of part of this work have been published (Chase & Tubbs, 1966b , 1967 .
MATERIALS
Enzymes. Pigeon breast muscle carnitine acetyltransferase was obtained from Boehringer Corp. (London) Ltd. (London, W. 5) and recrystallized twice to a specific activity of 120-130 units/mg. (Chase, Pearson & Tubbs, 1965) .
Citrate synthase (EC 4.1.3.7) was prepared from pig heart by the method of Srere & Kosicki (1961) .
Chemical&. CoA was bought from Boehringer Corp. (London) Ltd.; desulpho-CoA was prepared from it by the method of Chase, Middleton & Tubbs (1966) . Chloroacetyl chloride, bromoacetyl bromide, bromoacetic acid, thiophenol and ,B-alanine were the reagent grade of British Drug Houses Ltd. (Poole, Dorset). S-Carboxymethyl-2-mercaptoethylamine was prepared from 2-mercaptoethylamine hydrochloride (Koch-Light Laboratories Ltd., Colnbrook, Bucks.) by the method of De Marco, Riva & Dupre (1964) and recrystallized twice. (+)-, (-)-and (±)-Carnitine hydrochlorides were obtained from KochLight Laboratories Ltd.; samples of the two optically active isomers from British Drug Houses Ltd. were also used.
(+±)-[Me-14C]-Carnitine hydrochloride, nominally 11-65/Lc/ ,umole, was a gift from Dr P. B. Garland. Before use it was chromatographed on a column of Zeo-Karb 225 Bioch. 1969, 111 (SRC 16) cation-exchange resin (British Drug Houses Ltd.) by the procedure of Friedman, McFarlane, Bhattacharyya & Fraenkel (1960) . An emergent peak with 95% of the radioactivity of the starting material proved to contain all the carnitine. This material was pooled and stored frozen. 5,-5'-Dithiobis-(2-nitrobenzoic acid) was obtained from the Aldrich Chemical Co. Inc. (Milwaukee, Wis., U.S.A.). Tris (Trizma base; Sigma Chemical Co., St Louis, Mo., U.S.A.) was neutralized with HCI. Phosphate buffers were prepared from KH2PO4 and KOH.
Other reagents were of analytical grade and glassdistilled water was used throughout.
METHODS
Preparation of chloroacetyl-CoA and bromoacetyl-CoA. In the early stages ofthis work these compounds were prepared by treating CoA solutions with the appropriate haloacetyl halide (Seubert, 1960) . However, as this procedure gives rather poor yield (20-30%) of impure haloacetyl-CoA, a milder technique has been developed based on transhaloacetylation between thiophenol and CoA.
(i) Preparation of S-bromoacetylthiophenol. A 2-Oml. portion (19-2m-moles) of thiophenol was added to 2-4ml.
(26-4m-moles) of freshly redistilled bromoacetyl bromide in a Thunberg tube. HBr was removed as formed by means of a water pump. After about 60min. at room temperature no further gas was evolved and saturated KHCO3 solution was added to bring the pH of the mixture to about 8. This precipitated bromoacetylthiophenol as colourless crystals. The mixture was extracted twice with ether, which dissolved the crystals, and the aqueous supernatant was washed twice with this solvent. The ethereal solution was washed three times with dilute aqueous KHCO3 to remove traces of bromoacetic acid and dried with Na2SO4. Removal of the ether in a stream of N2 left a pale-yellow solid, which was recrystallized from aqueous ethanol. A yield of 2-7g. (57% of theory) of colourless bromoacetylthiophenol (m.p. 36.3-37.3°, uncorr.) was obtained. On storage at 40 in vacuo in the dark, bromoacetylthiophenol develops a yellow colour, and it was freshly recrystallized before use.
(ii) Bromoacetylation of CoA. A 0-5g. portion (2-Ommoles) of bromoacetylthiophenol was dissolved in 3ml. of acetone-0-1M-KHCO3 (5:2, v/v) and mixed with 20mg.
(approx. 20,umoles) of CoA dissolved in the same solvent.
This system was usually monophasic; if it was not, drops of acetone or KHCO3 were added as required. After 45min. at room temperature, the solution was brought to pH 1-2 with conc. HCI and the acetone removed with a stream of N2. The aqueous slurry that remained was extracted ten times with ether to remove thiophenol and acylthiophenol, and the last traces of ether were evaporated with N2 as before.
The pH of the solution was adjusted to 3 5-4-5 with KHCO3. About 75% of the CoA originally present was recovered as bromoacetyl-CoA, which may be stored frozen with only a low rate 'of decomposition (less than 5%/week).
A8aay of haloacetyl-CoA derivative8. Both chloroacetylCoA and bromoacetyl-CoA are substrates for citrate synthase. Solutions of these derivatives may therefore be assayed in the system described for acetyl-CoA (Chase, 1967a) , although the time taken for the reaction to reach equilibrium must be considerably extended and larger amounts (100-200,ug.) of citrate synthase used.
Preparation and assay of bromoacetylcarnitine. The bromoacetyl derivatives of (+)-, (-) and (±)-carnitine were prepared by treating the appropriate carnitine hydrochloride, dissolved in bromoacetic acid, with bromoacetyl bromide. The procedure was otherwise identical with that described by Fraenkel & Friedman (1957) for acetylcarnitine. Bromoacetylcarnitine was recrystallized twice from acetic acid-acetone (Chase & Tubbs, 1966a) and stored in a desiccator away from light.
No specific assay for bromoacetylcarnitine is available, as this compound strongly inhibits carnitine acetyltransferase. Two indirect methods have therefore been used. In the first, bromoacetylcarnitine was hydrolysed by incubation at room temperature for 10min. in the presence of a 0-1 M concentration excess of KOH. After neutralization the (-)-carnitine released was determined enzymically (Pearson & Tubbs, 1964) . This procedure can only be used with derivatives of (-)-or (±)-carnitine. Bromoacetyl esters of all carnitine enantiomers were also estimated chemically by a hydroxamate method (Friedman & Fraenkel, 1955) . The first method measures both free and alkali-labile carnitine in the sample, whereas the second measures all esters of carnitine, so that the reported concentrations of bromoacetylcarnitine are maximum values.
Sub8trate8 of carnitine acetyltransferase. Solutions of CoA, acetyl-CoA, (-)-carnitine and acetyl-(-)-carnitine were prepared, stored and assayed as described by Chase & Tubbs (1966a) .
Measurement8 of carnitine acetyltran8ferase activity. Except where specific conditions are mentioned, carnitine acetyltransferase activities were compared by adding enzyme samples to a system containing tris-HCl buffer, pH7-8 (100mm), acetyl-CoA (0-1mM) and (-)-carnitine hydrochloride (1-25mM) in a final volume of 2-Oml. The initial rate of decrease of E232, due to the deacetylation of CoA, was observed by using a Beckman DK-2 recording spectrophotometer with the cell housing maintained at 30+0-30.
Molecular-weight determination8. A single determination of the molecular weight of carnitine acetyltransferase was made by using the Archibald technique as modified by Ehrenberg (1957) . Observations on the meniscus at the air/solvent interface were carried out on a solution containing 9-85mg. of protein/ml. in 0-M-phosphate buffer, pH7-5, by using a Spinco model E analytical ultracentrifuge at 7950 rev./min. and 170. The subsequent artificialboundary experiment was conducted at 16000 rev./min. Calculated values for the molecular weight after 48, 64 and 80min. were 59300, 58900 and 57500 respectively. A value of 0-74 was taken for the partial specific volume of the enzyme. This was obtained from the amino acid composition (J. F. A. Chase, unpublished work) by the procedure of McMeekin & Marshall (1952) .
Two experiments were performed by using the 'shortcolumn' sedimentation-equilibrium technique of Yphantis (1960) . With 4-5mg. of protein/ml. dissolved in 0-03M-phosphate buffer, pH7-8, containing NaCl (0-1 m), these gave values for the molecular weight of 61120 and 60580.
A previous estimate of the molecular weight of carnitine acetyltransferase, obtained by gel filtration (Andrews, 1964) , was 55000 (Chase et al. 1965) . Taking this result with those reported above, the molecular weight of the enzyme has here been assumed to be 58000+3000.
Protein concentration. Carnitine acetyltransferase solu-tions were estimated spectrophotometrically, by taking El%. to be 8-25 at 280m,u. This value was obtained by submitting enzyme samples to micro-Kjeldahl digestion and determining their nitrogen content (as ammonia) with ninhydrin. It was then assumed that the protein contained 16% of nitrogen (Bailey, 1962, p. 300 for rapid inhibition of the enzyme to occur, it must be exposed simultaneously to CoA and bromoacetylcarnitine. Neither acetyl-CoA nor desulphoCoA will substitute for CoA in promoting inhibition.
In experiments similar to those of Fig. 1 , bromoacetyl-(+)-carnitine was found to be very much less inhibitory than the (-)-derivative. Thus, even at a concentration of 2 mM, only a very slow inhibition was observed and this may well have been due to trace (about 1 %) contamination with the natural isomer of the (+ )-carnitine used in the synthesis of bromoacetyl-( + )-carnitine.
Establishment of experimental conditions for the rapid inhibition of carnitine acetyltransferase by haloacetyl-CoA. In Fig. 2(a) it is shown that the addition of 0 4,uM-bromoacetyl-CoA to the reaction mixture used above caused virtually instant abolition of carnitine acetyltransferase activity. Even 0 02,tM-inhibitor stopped the reaction in about 1 min. (Fig. 2b) . Fig. 2 (c)-2(e) establish that for rapid inhibition to occur the enzyme must be simultaneously exposed to bromoacetyl-CoA and (-)-carnitine. (+ )-Carnitine, the unnatural isomer, did not promote inhibition by bromoacetylCoA (Fig. 2f) .
Enhancement of chloroacetyl-CoA inhibition by (-)-carnitine. Under the conditions of Fig. 2 , chloroacetyl-CoA inhibited in the same way as bromoacetyl-CoA. Loss of enzyme activity was, however, less rapid and this made it easier to investigate the quantitative effects of (-)-carnitine on the rate of inhibition. , affords considerable protection against inhibition by bromoacetyl-CoA.
Titration of carnitine acetyltran8ferase with bromoacetyl-(-)-carnitine. enzyme's activity is lost, the degree of inhibition observed is proportional to the amount of inhibitor added. By extrapolation it may be calculated that lmole of enzyme is inactivated by 0-97mole of inhibitor. Titration of carnitine acetyltran8fera8e with bromoacetyl-CoA. Oumoles of (-)-carnitine and 0-93 Lmole of bromoacetyl-CoA in a final volume of3-0ml. After 5min. at room temperature residual enzyme activity was less than 1%. Excess of inhibitor was then removed from the enzyme by passage through a column of Sephadex G-25 as described for the experiment shown in Fig. 7 . The eluted protein in a volume of 24ml. was stored at 40, and 1,I. samples were assayed for carnitine acetyltransferase activity over a period of about 6 weeks. Control samples of enzyme showed less than 5% loss of activity after a corresponding time in the refrigerator.
removal of excess of inhibitor by gel filtration, showed a slow progressive recovery of activity on standing at 4° (Fig. 6 ). The rate of this process followed pseudo-first-order kinetics with a halftime of about 14-8 days. After 37 days 85% of the original activity was present; thereafter reactivation took place more slowly and never exceeded 89% (51 days).
Enzyme that had been inhibited with bromoacetylcarnitine plus CoA (Fig. 1) (Chase & Tubbs, 1966a) . A hypothesis developed from these observations is illustrated in Scheme 1. It is assumed that, after independent binding of bromoacetylCoA and (-)-carnitine to the usual enzyme sites for CoA and carnitine derivatives (Scheme la), transfer of the bromoacetyl group from CoA to carnitine takes place by the normal catalytic mechanism (Scheme lb). This is not unreasonable as the enzyme has a broad specificity for the transfer of short-chain acyl groups (Chase, 1967b Fig. 7 with O-1M-phosphate buffer, pH7-1. Extinction measurements over a 10mm. light-path were made by using a Unicam SP. 500 spectrophotometer. The protein concentration of the inhibited enzyme solution was obtained by the microbiuret method (Bailey, 1962, p. column (2cm. x 35cm. ) of Sephadex G-25 equilibrated with 0-M-phosphate buffer, pH7-0, and was eluted with the same buffer; 26-drop fractions were collected automatically. Fig. 7 shows the elution pattern of protein and unchanged bromoacetyl-CoA as determined from the E260 value of each fraction. Samples (100ul.) were also taken for radioactivity determinations to show the fate of the carnitine label.
Ab8orption 8pectrum of the inhibited enzyme. A difference spectrum (curve C in Fig. 8 ) may be calculated by comparing the spectrum of inhibited carnitine acetyltransferase (curve A in Fig. 8) with that of the native enzyme (curve B in Fig. 8 ). It has a peak at 260m,u, which could be caused by an adenine nucleotide residue bound to the inhibited enzyme.
Radioactivity a8sociated with the inhibited enzyme. Fractions 11-15 of the eluate from Sephadex G-25 (Fig. 7) were pooled and found to contain 41-3mg.
of protein (0-71 ,umole). Assay of this enzyme, immediately after gel filtration, showed it to have 18% of the specific activity of the original carnitine acetyltransferase. The radioactivity associated with this protein was equivalent to that from 0'43,umole of the (-)-carnitine used to promote inhibition. Thus, if it is assumed that no radioactivity was bound to reactivated enzyme, each mole of inhibited enzyme contained 0-74mole of a (-)-carnitine derivative.
Relea8e of radioactivity from the inhibited enzyme. Preliminary experiments showed that neither precipitation of the enzyme with ammonium sulphate nor its adsorption on calcium phosphate gel and subsequent elution promoted release of radioactivity from the protein or the return of its catalytic function. However, irreversible denaturation of the enzyme with trichloroacetic acid followed by passage through a Millipore filter left more than 90% of the radioactivity in the filtrate.
To 9-5 ml. of inhibited enzyme (39mg., 0-67,umole) from the experiment shown in Fig. 7 was added an equal volume of cold 5% (w/v) trichloroacetic acid. Denatured protein was removed by centrifugation and washed once with cold 2-5% trichloroacetic acid. The volume of the combined supernatant and washings was reduced to 4-7ml. by rotary evaporation (bath temperature 300) and trichloroacetic acid was removed by extracting six times with ether.
The sample was diluted to 50ml. with water and applied to a column (1-S5cm. x 21 cm.) of DEAEcellulose equilibrated with 3mM-hydrochloric acid. Elution was performed with a salt gradient, the mixing vessel originally holding 100ml. of 3mM-hydrochloric acid, and the reservoir 100ml. of 3mM-hydrochloric acid containing 0-25M-potassium chloride (Moffatt & Khorana, 1961) ; 26-drop was added and, after 5min. at room temperature, less than 0-3% of the original enzyme activity was detectable.
The entire reaction mixture (3 95 ml.) was applied fractions were collected automatically. The E260 value of each fraction was measured and 25,1 . samples were taken for radioactivity determinations (Fig. 9) . A single sharp peak of 260m,-absorbing material emerged coincidentally with all the radioactivity of the sample. Fractions 45-48, which comprised this peak, were pooled for analysis.
Analy8i8 of the pooled material: identification of S-carboxymethyl-CoA (-)-carnitine e8ter. (i) Ultraviolet-absorption spectrum. This was measured both at pH2.7 and at pH 7.0. In acid there was an extinction maximum at 257 m,, a minimum at 230-5m,u and the E280/E260 ratio was 0-202. In neutral solution the maximum was at 260mp, the minimum at 228m,u and the E2so/E260 ratio was 0-136. These values agree well with published data for adenine nucleotides (Beaven, Holiday & Johnson, 1955) . Assuming the molar extinction coefficient for adenine nucleotides in acid solution to be 14-2 x 103cm.-l at 260m,u (Beaven et al. 1955) , the total yield of nucleotide was calculated to be 0-33,umole.
(ii) Alkali-labile (-)-carnitine content of the nucleotide. The radioactivity associated with the nucleotide was that present in 0-366,umole of the [14C]carnitine used to promote inhibition of the original enzyme.
Three samples of nucleotide were adjusted to 0-1 M concentration excess of potassium hydroxide and left at room temperature for 20min. They were then neutralized with hydrochloric acid and assayed for (-)-carnitine (Chase & Tubbs, 1966a) , together with another nucleotide sample that had not been exposed to alkali. It was found ( Table 2) that each mole of nucleotide contained about 1 mole of (-)-carnitine and that at least 95% of this carnitine was released only on alkaline hydrolysis.
(iii) Acid hydrolysis of the nucleotide. A sample containing 0-205B,mole of nucleotide was evaporated to dryness in a rotary evaporator, dissolved in 1 ml. of 6M-hydrochloric acid and hydrolysed in a sealed evacuated tube for 18hr. at 1050. The hydrolysate, after evaporation to dryness, was dissolved in 1ml. of 0-1M-hydrochloric acid and applied to a Technicon AutoAnalyzer. It proved to contain stoicheiometric amounts of ,-alanine and S -carboxymethyl -2 -mercaptoethylamine (Table 2) . This analysis strongly suggests that the nucleotide formed during the inhibition ofcarnitine acetyltransferase by bromoacetyl-CoA plus (-)-carnitine is indeed S-carboxymethyl-CoA (-)-carnitine ester, as predicted in Scheme 1. Its spectrum is that of an adenine nucleotide and it contains (-)-carnitine in a form with the alkali-lability expected of acid-soluble carnitine O-esters (Pearson, Chase & Tubbs, 1969 Inhibition of carnitine acetyltranaferase by isolated S-carboxymethyl-CoA (-)-carnitine e8ter. An incubation mixture containing 6 8 uM-carnitine acetyltransferase, 15,nm-S-carboxymethyl-CoA (-)-carnitine ester (isolated from inhibited enzyme as described above) and 25mM-phosphate buffer, pH 7-0, was kept at room temperature. Samples were removed at intervals and assayed for enzyme activity. A very slow loss of activity was observed (Fig. 10) , the degree of inhibition never exceeding 80%, even after 26hr. A control from which the nucleotide was omitted showed no loss of activity over this period.
DISCUSSION
The results described here demonstrate that the rapid inhibition of carnitine acetyltransferase by bromoacetyl derivatives of CoA and (-)-carnitine may be represented by Scheme 1. Certain aspects of the inhibition, however, require further comment.
First, the alkylation of CoA by bromoacetyl-( -)-carnitine, which takes place within the enzymesubstrate ternary complex, is an extraordinarily fast reaction. Bromoacetylcarnitine is not in itself an unusually powerful alkylating agent. Thus, in an attempt to prepare S-carboxymethyl-CoA (-)-carnitine ester synthetically, a mixture containing 15mM-CoA and l40mM-bromoacetyl-(-)-carnitine was kept at room temperature at pH 8-9; complete reaction, as judged by the mixture becoming nitroprusside-negative, was achieved only after 60-90min. In contrast, in Fig. 2(a) , at a maximum concentration of enzyme-bound bromoacetyl-CoA and (-)-carnitine of 5nm, complete inhibition takes less than 5sec. This short time is sufficient for both the alkylation and for the essential preliminary transbromoacetylation (Scheme la-b); in fact the latter must determine the rate at which inhibition develops, as the stoicheiometry of the reaction of carnitine acetyltransferase with bromoacetyl-CoA (Fig. 5) requires that virtually none of the bromoacetylcarnitine formed as an intermediate (Scheme lb) is released from the enzyme before taking part in the alkylation of CoA. Presumably the enzyme's ability to accelerate the alkylation reaction results solely from its capacity to bind the reactants in close proximity and in a favourable orientation (Koshland, 1960) , rather than from any specific chemical catalysis.
An explanation must also be sought as to why the enzyme is so powerfully inhibited by S-carboxymethyl-CoA (-)-carnitine ester formed in 8itU. This adduct of the two substrates is imagined as forming a 'bridge' between the independent CoAand carnitine-binding sites, previously proposed to exist on this enzyme on kinetic grounds (Chase & Tubbs, 1966b; Chase, 1967a,b) . On a naive interpretation, it might be expected that this inhibitor would be bound to the enzyme with a free energy of binding roughly equal to the sum of the binding energies of CoA and carnitine derivatives. Thus, by taking the product of the dissociation constants for short-chain acyl-CoA derivatives and for acetyl- (Chase, 1967b ) and 350pM (Chase & Tubbs, 1966a) , respectively], a value of 1-2 x 10-8M might be expected for the K, of the adduct. However, the equilibrium formation of an enzyme-inhibitor complex with such a dissociation constant cannot explain the observed results. For example, in the experiment shown in Fig. 4 , in which the enzyme was assayed at a concentration of 6-25nM, virtually no inhibition would have been observed when less than stoicheiometric amounts of bromoacetylcarnitine had been added. It is, of course, possible that the dissociation constant deduced above for the adduct might be much too high, for simple multiplication of the component dissociation constants may not be appropriate. For metal complexes it is well known that the free energy of binding of a multidentate ligand (here the adduct) is greater than the sum of the free energies of binding of its individual parts; this is due to slow dissociation of the complex rather than to its accelerated formation (Martell & Calvin, 1952) . Such a chelate effect could presumably also contribute to enzyme-inhibitor (or, indeed, to enzyme-substrate) interactions. Another possibility is that adduct formation is accompanied by a conformational change in the enzyme-inhibitor complex, which enhances binding.
A number of cases are known of protein-small molecule complexes with very low dissociation constants. Although in principle such constants give no indication of the absolute rates of formation and breakdown of complexes, in practice low values are usually caused by slow breakdown. For example, the pseudo-first-order release of FAD from D-amino acid oxidase has a half-time of 133sec., K, for coenzyme binding being 2 5 x 10-7M (Dixon & Kleppe, 1965) ; aminopterin, which inhibits folate reductase with KJ about 10-10M, dissociates from the enzyme-inhibitor complex with a half-time of 5-4 x 105sec. (Werkheiser, 1961) ; and in the extreme case of the combination of biotin with avidin, Ks 10-15M is accompanied by a halftime for dissociation of 1.1 x 107sec. (Green, 1963) . Fig. 6 shows that carnitine acetyltransferase recovers from inhibition by bound adduct with a half-time of 14-8 days. Since this virtually complete recovery occurs in comparatively concentrated solution (28tM) it cannot be due to the slow dissociation of an inhibitor of high affinity. Fig. 10 shows that, as expected, added S-carboxymethylCoA (-)-carnitine ester inhibits the enzyme. However, for a non-covalent interaction, the process is unusually slow and contrasts strongly with the virtually instant inhibition observed when the adduct is formed in sttu. Other examples of sluggish combination between enzymes and complex small molecules are known, e.g. the slow reactivation of yeast apo-pyruvate decarboxylase by thiamine pyrophosphate (Morey & Juni, 1968) . Possibly the favoured configuration of the adduct in free solution is unsuitable for binding; it is well known that NAD and FAD, which have structural similarities to CoA derivatives, have preferred conformations (Kaplan, 1960; Beinert, 1960) . Equally the structure of the protein may be such as to hinder sterically both binding and desorption of the adduct.
The exceedingly potent inhibition of carnitine acetyltransferase by S-carboxymethyl-CoA (-)-carnitine ester, when formed in 8itU, is evidently a consequence, not of a very small dissociation constant, but rather of the very low rate of adduct release, i.e. it is a kinetic and not an equilibrium effect. Possible explanations of this slow dissociation have been discussed above. It is probable that the recovery from inhibition (Fig. 6) is largely governed by the hydrolysis of S-carboxymethylCoA (-)-carnitine ester either in 8itu or after release (Scheme lc-f). The equilibrium constant for the reversible binding of the adduct by the enzyme has not been measured. Indeed, for reasons already discussed above, it would not be directly relevant to the observed inhibition effects. The ability of the enzyme to promote the formation of S-carboxymethyl-CoA (-)-carnitine ester directly demonstrates that it can bind CoA and carnitine simultaneously, confirming the existence of a ternary complex previously inferred from kinetic evidence (Chase & Tubbs, 1966a) . Indeed, the isolated inhibited enzyme may be regarded as a 'frozen' ternary enzyme-substrate complex.
Since carnitine palmitoyltransferase (EC 2.3.1.-) is powerfully inhibited by 2-bromolauroyl-CoA (or 2-bromostearoyl-CoA) in a (-)-carnitine-dependent manner , its action too presumably involves the simultaneous binding of both substrates. Such also appears to be the case with choline acetyltransferase (EC 2.3.1.6), for the inhibition of this enzyme by bromoacetyl-CoA is choline-dependent (Chase & Tubbs, 1966b) , although such a conclusion is at variance with the kinetic studies of Schuberth (1966) .
Finally, it may be noted that carnitine acetyl. and palmitoyl-transferases can be inhibited in intact mitochondria by the mechanism described in this paper. This fact has been used to demonstrate (Tubbs & Chase, 1966 , 1967 ) that each of these enzymes exists in two mitochondrial pools, only one ofwhich is inactivated by externally added bromoacyl-CoA plus (-)-carnitine. The other pool is, however, inhibited by bromoacylcarnitine plus intramitochondrial CoA.
